Dr. Thomas A. Moore, MD

Dr. Moore practices at Wesley Medical Center in Wichita, Kansas, part of HCA Healthcare.

Dr. Moore's NPI, 1407851181, was assigned on June 17, 2005. Dr. Moore graduated from University of Kansas School of Medicine - Kansas City in 1989. Dr. Moore's Kansas license number on file is 0423399.

Dr. Moore's primary practice is Wesley Medical Center, at 550 N Hillside Street, Wichita, KS 67214 in Sedgwick County. The practice phone is (316) 962-2000.

Dr. Moore's primary practice is Wesley Medical Center in Wichita, Kansas, part of HCA Healthcare. Dr. Moore is also affiliated with Ascension Via Christi St. Francis. The medical group on file is Infectious Disease Consultants. Dmand AI also links Dr. Moore to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moore practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Moore's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Moore is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Moore's licenses on file in 2 states: Kansas and Louisiana.

Dmand AI lists acute skin infection, endocarditis, immune deficiency disease, joint or bone infection and UTI among the conditions Dr. Moore treats.

CMS data shows 213,650 Medicare services from Dr. Moore across 18 procedure codes in 2024, for 843 Medicare patients. Medicare paid $947,446 for them.

CMS counts 843 Medicare patients who saw Dr. Moore in 2024. The largest group is 65 to 74, with 359 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moore's median patient age at 67, with 51% women.

In 2024, Dr. Moore wrote 577 Medicare Part D claims for 186 patients. 95% of them were for generic drugs. CMS names the drug for 454 of them, across 17 drugs with 11 or more claims each, at $60,937 in total drug cost. In 2023, CMS named 263 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Moore for performance year 2024, reported individually. Dr. Moore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Moore as offering telehealth.

Dmand AI links 31 papers to Dr. Moore, published from 2001 to 2022. 2012 was the busiest year, with 3. The most frequent topics are Feces, Biological Therapy and Clostridioides difficile. Dr. Moore has published most often in Clin Infect Dis. Dr. Moore's most frequent co-authors are Stacy A. Kahn, MD, Johan Septimus Bakken, MD and Imad Absah, MD.

CMS Open Payments shows 128 general payments to Dr. Moore from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Aimmune Therapeutics, Inc. paid the most, $35,984.

Dr. Moore graduated from University of Kansas School of Medicine - Kansas City in 1989. Dr. Moore is a member of ACP, American Society of Tropical Medicine and Hygiene and Infectious Disease Society of America (IDSA).

Dr. Moore is in network with 18 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.